Company Filing History:
Years Active: 2001-2003
Title: Innovations and Contributions of Johannes Regenbogen
Introduction
Johannes Regenbogen is a notable inventor based in Martinsried, Germany. He has made significant contributions to the field of biotechnology, particularly in the diagnosis and treatment of skin disorders and wound healing. His work has led to the development of innovative methods that have the potential to improve patient outcomes.
Latest Patents
Johannes Regenbogen holds 2 patents that focus on the use of polypeptides and nucleic acids for medical applications. His latest patents include:
1. "Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances."
2. "Method of using polypeptides or nucleic acids encoding these for the diagnosis and/or prevention and/or treatment of diseases of skin cells and/or of wound healing and/or its pathological disorders, and their use for the identification of pharmacologically active substances."
3. "Cloning vectors and their preparation and use for mRNA expression pattern analysis."
Career Highlights
Johannes Regenbogen is currently associated with Switch Biotech AG, where he continues to advance his research and innovations. His work is pivotal in the development of new therapeutic strategies that address complex medical challenges.
Collaborations
He collaborates with esteemed colleagues such as Jörn-Peter Halle and Andreas Goppelt, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Johannes Regenbogen's contributions to biotechnology through his patents and collaborative efforts highlight his role as a key innovator in the field. His work promises to enhance the understanding and treatment of skin disorders and wound healing, ultimately benefiting patients worldwide.